Garcia D, Erkan D. Diagnosis and management of the Antiphospholipid Syndrome. N Engl J Med. 2018;378(21):2010–21. https://doi.org/10.1056/NEJMra1705454.

Article  PubMed  Google Scholar 

Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-García A. Epidemiology of Antiphospholipid Syndrome in the General Population. Current rheumatology reports. 2022;23(12):85.10.1007/s11926-021-01038-2.

Knight JS, Kanthi Y. Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome. Semin Immunopathol. 2022;44(3):347 – 62.10.1007/s00281-022-00916-w.

Martinelli I, Abbattista M, Bucciarelli P, Tripodi A, Artoni A, Gianniello F et al. Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban. Haematologica. 2018;103(7):e315-e7.10.3324/haematol.2017.185132.

Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532 – 5.10.1126/science.1092385.

Salet DM, Bekkering S, Middeldorp S, van den Hoogen LL. Targeting thromboinflammation in antiphospholipid syndrome. Journal of thrombosis and haemostasis: JTH. 2023;21(4):744 – 57.10.1016/j.jtha.2022.12.002.

Wigerblad G, Kaplan MJ. Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases. Nat Rev Immunol. 2023;23(5):274–88. https://doi.org/10.1038/s41577-022-00787-0.

Article  PubMed  Google Scholar 

Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C et al. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis & rheumatology (Hoboken, NJ). 2015;67(11):2990-3003.10.1002/art.39247.

Meng H, Yalavarthi S, Kanthi Y, Mazza LF, Elfline MA, Luke CE, et al. In vivo role of Neutrophil Extracellular traps in Antiphospholipid antibody-mediated venous thrombosis. Arthritis Rheumatol (Hoboken NJ). 2017;69(3):655–67. https://doi.org/10.1002/art.39938.

Article  Google Scholar 

Powell WS, Rokach J. Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE. Prog Lipid Res. 2005;44(2–3):154–83. https://doi.org/10.1016/j.plipres.2005.04.002.

Article  PubMed  Google Scholar 

Graham FD, Erlemann KR, Gravel S, Rokach J, Powell WS. Oxidative stress-induced changes in pyridine nucleotides and chemoattractant 5-lipoxygenase products in aging neutrophils. Free radical biology & medicine. 2009;47(1):62-71.10.1016/j.freeradbiomed.2009.04.016.

Powell WS, Gravel S, MacLeod RJ, Mills E, Hashefi M. Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor. J Biol Chem. 1993;268(13):9280–6.

Article  PubMed  Google Scholar 

Ma Y, Hui KL, Gelashvili Z, Niethammer P. Oxoeicosanoid signaling mediates early antimicrobial defense in zebrafish. Cell Rep. 2023;42(1):111974.10.1016/j.celrep.2022.111974.

Surmiak M, Gielicz A, Stojkov D, Szatanek R, Wawrzycka-Adamczyk K, Yousefi S, et al. LTB(4) and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis. J Lipid Res. 2020;61(1):1–9. https://doi.org/10.1194/jlr.M092072.

Article  PubMed  Google Scholar 

Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nature medicine. 2009;15(6):623 – 5.10.1038/nm.1959.

Ali RA, Gandhi AA, Meng H, Yalavarthi S, Vreede AP, Estes SK et al. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nature communications. 2019;10(1):1916.10.1038/s41467-019-09801-x.

Futosi K, Fodor S, Mócsai A. Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int Immunopharmacol. 2013;17(3):638–50. https://doi.org/10.1016/j.intimp.2013.06.034.

Article  PubMed  PubMed Central  Google Scholar 

Powell WS, Rokach J. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid. Biochim Biophys Acta. 2015;1851(4):340–55. https://doi.org/10.1016/j.bbalip.2014.10.008.

Article  PubMed  Google Scholar 

Damascena HL, Silveira WAA, Castro MS, Fontes W. Neutrophil activated by the Famous and Potent PMA (Phorbol Myristate acetate). Cells. 2022;11(18). https://doi.org/10.3390/cells11182889.

Vorobjeva NV, Chernyak BV. NETosis: Molecular mechanisms, Role in Physiology and Pathology. Biochem Biokhimiia. 2020;85(10):1178–90. https://doi.org/10.1134/s0006297920100065.

Article  Google Scholar 

Mazetto BM, Hounkpe BW, da Silva Saraiva S, Vieira-Damiani G, Dos Santos APR, Jacinto BC et al. Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome. Thrombosis research. 2022;214:132 – 7.10.1016/j.thromres.2022.05.001.

Grossi C, Capitani N, Benagiano M, Baldari CT, Della Bella C, Macor P, et al. Beta 2 glycoprotein I and neutrophil extracellular traps: potential bridge between innate and adaptive immunity in anti-phospholipid syndrome. Front Immunol. 2022;13:1076167. https://doi.org/10.3389/fimmu.2022.1076167.

Article  PubMed  Google Scholar 

Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Annals of the rheumatic diseases. 2015;74(6):1011 – 8.10.1136/annrheumdis-2013-204838.

Thrombosis: a major contributor to the global disease burden. Journal of thrombosis and haemostasis: JTH. 2014;12(10):1580 – 90.10.1111/jth.12698.

Drosos D GC, Vedder, Houben E, Boekel L, Atzeni F, Badreh S, et al. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022;81(6):768–79. https://doi.org/10.1136/annrheumdis-2021-221733.

Article  PubMed  Google Scholar 

Pazzola G, Zuily S, Erkan D. The challenge of bleeding in antiphospholipid antibody-positive patients. Current rheumatology reports. 2015;17(2):7.10.1007/s11926-014-0481-0.

Powell WS, Zhang Y, Gravel S. Effects of phorbol myristate acetate on the synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid by human polymorphonuclear leukocytes. Biochemistry. 1994;33(13):3927–33. https://doi.org/10.1021/bi00179a019.

Article  PubMed  Google Scholar 

Blättermann S, Peters L, Ottersbach PA, Bock A, Konya V, Weaver CD, et al. A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimer. Nat Chem Biol. 2012;8(7):631–8. https://doi.org/10.1038/nchembio.962.

Article  PubMed  Google Scholar 

Lai Q, Yuan G, Shen L, Zhang L, Fu F, Liu Z et al. Oxoeicosanoid receptor inhibition alleviates acute myocardial infarction through activation of BCAT1. Basic Res Cardiol. 2021;116(1):3.10.1007/s00395-021-00844-0.

Cooke M, Di Cónsoli H, Maloberti P, Cornejo Maciel F. Expression and function of OXE receptor, an eicosanoid receptor, in steroidogenic cells. Mol Cell Endocrinol. 2013;371(1–2):71 – 8.10.1016/j.mce.2012.11.003.